scholarly article | Q13442814 |
P2093 | author name string | Amit Kishore | |
Lenka Kocourková | |||
Martin Petřek | |||
Veronika Žižková | |||
P2860 | cites work | A simple salting out procedure for extracting DNA from human nucleated cells | Q27861086 |
Angiostatic versus angiogenic chemokines in IPF and EAA | Q84079375 | ||
MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis | Q86514742 | ||
TGF-β-induced epithelial-to-mesenchymal transition proceeds through stepwise activation of multiple feedback loops | Q28248954 | ||
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis | Q28283421 | ||
Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis | Q28291143 | ||
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management | Q28308246 | ||
Muc5b is required for airway defence | Q28589969 | ||
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis | Q28943334 | ||
Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study | Q28943525 | ||
New mechanisms of pulmonary fibrosis | Q30434264 | ||
Evaluation of HapMap data in six populations of European descent | Q31152012 | ||
CXCR3 Requirement for the Interleukin-13-Mediated Up-Regulation of Interleukin-13Rα2 in Pulmonary Fibroblasts | Q33756881 | ||
Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model. | Q33799732 | ||
Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males | Q34046860 | ||
Genotyping with Sequenom | Q34069508 | ||
Association between variations in cell cycle genes and idiopathic pulmonary fibrosis | Q34146071 | ||
Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendations | Q34245542 | ||
The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population | Q34935466 | ||
The MUC5B promoter polymorphism is associated with idiopathic pulmonary fibrosis in a Mexican cohort but is rare among Asian ancestries. | Q35041524 | ||
A promoter SNP rs4073T>A in the common allele of the interleukin 8 gene is associated with the development of idiopathic pulmonary fibrosis via the IL-8 protein enhancing mode | Q35121363 | ||
TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis | Q35606977 | ||
Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis | Q35683018 | ||
A common MUC5B promoter polymorphism and pulmonary fibrosis. | Q36048530 | ||
Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion | Q36054682 | ||
Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis | Q36485998 | ||
Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis | Q36493970 | ||
A tutorial on statistical methods for population association studies | Q36597327 | ||
Targeting defective Toll-like receptor-3 function and idiopathic pulmonary fibrosis | Q38296340 | ||
Aberrant innate immune sensing leads to the rapid progression of idiopathic pulmonary fibrosis | Q42021416 | ||
Investigation of the fine structure of European populations with applications to disease association studies | Q44199896 | ||
IL-4 polymorphisms, HRCT score and lung tissue markers in idiopathic pulmonary fibrosis. | Q47869014 | ||
Angiotensin-converting enzyme (ACE) gene polymorphisms are associated with idiopathic pulmonary fibrosis. | Q51009584 | ||
Association of the SNP rs1800925(C/T) in the interleukin-13 gene promoter with pulmonary function in Chinese Han patients with idiopathic pulmonary fibrosis. | Q53113442 | ||
The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis. | Q54241841 | ||
Distribution of 22 cytokine gene polymorphisms in the healthy Czech population. | Q54588395 | ||
Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement | Q56565716 | ||
Idiopathic pulmonary fibrosis: An update | Q57762744 | ||
Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis | Q73337805 | ||
Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis | Q77487068 | ||
Different angiogenic activity in pulmonary sarcoidosis and idiopathic pulmonary fibrosis | Q79225746 | ||
P921 | main subject | Czech Republic | Q213 |
pulmonary fibrosis | Q32446 | ||
idiopathic pulmonary fibrosis | Q2290446 | ||
P304 | page(s) | 476 | |
P577 | publication date | 2015-09-22 | |
P1433 | published in | Frontiers in Immunology | Q27723748 |
P1476 | title | A Dataset of 26 Candidate Gene and Pro-Inflammatory Cytokine Variants for Association Studies in Idiopathic Pulmonary Fibrosis: Frequency Distribution in Normal Czech Population | |
P478 | volume | 6 |
Search more.